|
|
||||||||
1 Teagasc, Moorepark, Fermoy, County Cork, Ireland
2 University College Cork, Ireland
Cheddar cheese was evaluated as a food carrier for the delivery of viable microorganisms of Enterococcus faecium (Fargo 688®; Quest Int., Naarden, The Netherlands) to the gastrointestinal tract. This strain had previously been shown to possess properties required of a probiotic microorganism including the ability to relieve irritable bowel syndrome. The strain was found to survive to high numbers in Cheddar cheese during ripening at 8°C for 15 mo (4 x 108 cfu/g) and in yogurt during storage at 4°C for 21 d (4 x 107 cfu/g). In an in vitro model system, Cheddar cheese was found to have a greater protective effect than yogurt upon exposure of the probiotic culture to porcine gastric juice at pH 2. Subsequently, a feeding trial involving 8 pigs per group was performed in which a rifampicin-resistant variant of the probiotic strain was fed for 21 d at a mean daily intake of 1.3 x 1010 cfu/d from Cheddar cheese or 3.7 x 109 cfu/d from yogurt. During the feeding period, Cheddar cheese yielded a significantly higher mean fecal probiotic count (2 x 106 cfu/g of feces) than did yogurt (5.2 x 105 cfu/g of feces). These data indicate that mature Cheddar cheese compares very favorably with fresh yogurt as a delivery system for viable probiotic microorganisms to the gastrointestinal tract.
Key Words: probiotic Cheddar cheese carrier viable
Submitted on October 30, 1998
Accepted on February 22, 1999
This article has been cited by other articles:
![]() |
B. M. Corcoran, C. Stanton, G. F. Fitzgerald, and R. P. Ross Growth of probiotic lactobacilli in the presence of oleic acid enhances subsequent survival in gastric juice Microbiology, January 1, 2007; 153(1): 291 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Gardiner, P. G. Casey, G. Casey, P. B. Lynch, P. G. Lawlor, C. Hill, G. F. Fitzgerald, C. Stanton, and R. P. Ross Relative Ability of Orally Administered Lactobacillus murinus To Predominate and Persist in the Porcine Gastrointestinal Tract Appl. Envir. Microbiol., April 1, 2004; 70(4): 1895 - 1906. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stanton, G. Gardiner, H. Meehan, K. Collins, G. Fitzgerald, P B. Lynch, and R P. Ross Market potential for probiotics Am. J. Clinical Nutrition, February 1, 2001; 73(2): 476S - 483. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |